v3.26.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Accounts Receivable

The following is a summary of the Company’s accounts receivable at June 30, 2026 and December 31, 2025:

 

   June 30,   December 31, 
   2026   2025 
         
Accounts receivable  $2,973,462   $2,108,395 
Less: allowance for doubtful accounts   60,181    69,181 
Accounts receivable - net  $2,913,281   $2,039,214 
Schedule of Bad Debt

For the six months ended June 30, 2026 and 2025, bad debt was as follows:

 

   June 30,   June 30, 
   2026   2025 
Bad debt expense  $5,598   $11,264 
Schedule of Concentration of Risk

The following table presents customers and vendors that individually accounted for more than 10% of total sales, accounts receivable, or vendor purchases in the comparative periods presented:

 

Sales

 

Customer      
   Six Months Ended June 30, 
Customer  2026   2025 
A   55.78%   47.80%
Total   55.78%   47.80%

 

Accounts Receivable

 

Customer      
  June 30,   December 31, 
Customer  2026   2025 
A    0.00%   22.42%
B   37.46%   20.17%
C   8.86%   10.73%
Total   46.32%   53.32%

 

Vendor Purchases

 

Vendor      
   Six Months Ended June 30, 
Vendor  2026   2025 
A   3.19%   60.10%
B   0.19%   18.91%
C   0.01%   11.40%
D   10.96%   8.89%
Total   14.35%   99.30%
Schedule of Disaggregation of Revenue

The following represents the Company’s disaggregation of revenues for the six months ended June 30, 2026 and 2025:

 

   Six Months Ended June 30, 
   2026    2025 
   Revenue  

% of

Revenues

   Revenue  

% of

Revenues

 
                 
Fuel sales  $47,116,549    96.54%  $35,000,884    97.32%
Other   1,690,528    3.46%   963,357    2.68%
Total Sales  $48,807,078    100.00%  $35,964,241    100.00%
Schedule of Marketing and Advertising Costs

The Company recognized marketing and advertising costs during the six months ended June 30, 2026 and 2025, respectively as follows:

 

   2026   2025 
   Six Months Ended 
   June 30, 
   2026   2025 
         
Total Sales and Marketing  $150,514   $236,921 
Schedule of Dilutive Equity Securities Outstanding

The following potentially dilutive equity securities outstanding for the six months ended June 30, 2026 and 2025, were as follows:

 

   June 30, 2026   June 30, 2025 
Series A, convertible preferred stock   -    1,644,022 
Series B, convertible preferred stock   724,638    724,638 
Series A, convertible preferred stock - dividends   -    - 
Series B, convertible preferred stock - dividends   21,739    - 
Convertible notes     172,308       -  
Warrants (vested)   2,726,860    277,282 
Total common stock equivalents   3,681,545    2,645,942